Prevalence and clinical features of newly diagnosed generalized anxiety disorder patients in Spanish primary care settings: The GADAP study

Actas Espanolas de Psiquiatria

Volumn 40, Issue 3, 2012, Pages 105-113

  Garcia Campayo, Javier ^a   Caballero, Fernando ^b   Perez, Maria ^c   Lopez, Vanessa ^c  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

^c PFIZER INC   (United States)

Author keywords

Generalized anxiety disorder Primary care; Healthcare resources; Treatment

Indexed keywords

ANXIETY DISORDER; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; PRIMARY HEALTH CARE; SPAIN;

ANXIETY DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; SPAIN;

EID: 84873657585     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV TR. Washington DC, 2000.
2. Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004;Suppl(420):21-7.
3. Kessler RC, Chiu WT, Dernier O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-27.
4. Wittchen HU, Kessler RC, Beesdo K, et al. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry. 2002;63(Suppl 8):24-34.
5. Ansseau M, Fischler B, Dierick M, et al. Prevalence and impact of generalized anxiety disorder and major depression in primary care in Belgium and Luxemburg: the GADIS study. Eur Psychiatry. 2005;20(3):229-35.
6. Serrano-Bianco A, Palao DJ, Luciano JV, et al. Prevalence of mental disorders in primary care: results from the diagnosis and treatment of mental disorders in primary care study (DASMAP). Soc Psychiatry Psychiatr Epidemiol. 2010;45(2):201-10.
7. Beesdo K, Pine DS, Lieb R, Wittchen HU. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry. 2010;67 (1):47-57.
8. Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of Evidence-Based Treatment for Multiple Anxiety Disorders in Primary Care: A Randomized Controlled Trial. JAMA. 2010;303(19):1921-8.
9. Kessler RC, Andrade LH, Bijl RV, et al. The effects of co-morbidity on the onset and persistence of generalized anxiety disorder in the ICPE surveys. International Consortium in Psychiatric Epidemiology. Psychol Med. 2002;32(7):1213-25.
10. Revicki DA, Brandenburg N, Matza L, et al. 2008. Health-related quality of life and utilities in primary-care patients with generalized anxiety disorder. Qual Life Res 17(10):1285-94.
11. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262(7):914-9.
12. Wittchen HU, Carter RM, Pfister H, et al. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol. 2000;15(6):319-28.
13. Sicras-Mainar A, Blanca-Tamayo M, Navarro-Artieda R, et al. Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings. Aten Primaria. 2009;41(2):77-84.
14. Andlin-Sobocki P, Wittchen HU. Cost of anxiety disorders in Europe. Eur J Neurol. 2005;12(Suppl 1):39-44.
15. Norton J, de Roquefeuil G, David M, et al. Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription. Encephale. 2009;35(6):560-9.
16. Zhu B, Zhao Z, Ye W, et al. The cost of comorbid depression and pain for individuals diagnosed with generalized anxiety disorder. J Nerv Ment Dis. 2009;197(2):136-9.
17. Sheehan DV. Lecrubier Y. Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33; quiz 34-57.
18. Garcia-Campayo J, Zamorano E, Ruiz MA, et al. Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes. 2010;8:8.
19. Herrero MJ, Blanch J, Peri JM, et al. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry. 2003;25(4):277-83.
20. Hays RD. (2008). "SLEEP." Retrieved September 7th, 2009, from http://gim.med.ucla.edu/FacultyPages/Hays/SLEEP/sleep-download.html.
21. Spitzer RL, Kroenke K, Williams JBW, et al. A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Arch Intern Med. 2006;166(10):1092-7.
22. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70.
23. Badia X, Muriel C, Gracia A. Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain. Med Clin (Barc). 2003;120(2):52-9.
24. Kroenke K, Spitzer RL, Williams JBW, et al. Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection. Annals of Internal Medicine. 2007;146(5):317-25.
25. Brenes GA. Knudson M. McCall WV, et al. Ageand racial differences in the presentation and treatment of Generalized Anxiety Disorder in primary care. J Anxiety Disord. 2008;22(7):1128-36.
26. Kessler D, Lloyd K, Lewis G, et al. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. BMJ. 1999;318(7181): 436-9.
27. Weisberg RB, Dyck I, Culpepper L, et al. Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists. Am J Psychiatry. 2007; 164(2): 276-82.
28. Culpepper L 2009. Generalized anxiety disorder and medical illness. J Clin Psychiatry. 2009;70(Suppl 2):20-4.
29. Hartford JT, Endicott J, Kornstein SG, et al. Implications of Pain in Generalized Anxiety Disorder: Efficacy of Duloxetine. Prim Care Companion J Clin Psychiatry. 2008;10(3):197-204.
30. Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep. 2007;30(7):873-80.
31. Bollu V, Bushmakin AG, Cappelleri JC, et al. Pregabalin reduces sleep disturbance in patients with generalized anxiety disorder via both direct and indirect mechanisms. The European Journal of Psychiatry. 2010;4(1): DOI 10.4321/S0213-61632010000100003
32. Brawman-Mintzer O. Pharmacologic Treatment of Generalized Anxiety Disorder. The Psychiatric clinics of North America. 2001;24(1):119.
33. Bandelow B, Zohar J, Hollander E, et al., World Federation of Societies of Biological Psychiatry (WFSBP). Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders, First Revision. World Journal of Biological Psychiatry. 2008;9(4):248-312.
34. Romera I, Fernandez-Perez S, Montejo AL, et al. Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: Prevalence of painful somatic symptoms, functioning and health status. J Affect Disord. 2010 Dec;127(1-3):160-8.
35. Alvarez E, Carrasco J, Olivares J, et al. Broadening of Generalized Anxiety Disorder definition does not affect the response to psychiatric care: Findings form the observational ADAN study. European Psychiatry. 2010;25(Supp 1): PW01-50.
36. Loeppke R, Taitel M, Haufle V, et al. Health and productivity as a business strategy: a multiemployer study. J Occup Environ Med. 2009;51(4):411-28.
37. Hoffman DL, Dukes EM, Wittchen HU. Human and economic burden of generalized anxiety disorder. Depress Anxiety. 2008;25(1):72-90.